<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
14.01.2020 21:34:15

Illumina and Roche Combine For Genomics Oncology Deal

Top DNA sequencing company Illumina (NASDAQ: ILMN) has signed a pact with global pharmaceutical giant Roche (OTC: RHHBY) in the field of oncology, the Illumina's CEO Francis deSouza announced.On Monday, deSouza shared the news at the high-profile annual J.P. Morgan Healthcare Conference that his company and Roche signed a 15-year non-exclusive collaboration deal centered around next-generation sequencing (NGS) diagnostics in the field of oncology.Image source: Getty ImagesContinue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu Roche Holding AG (Inhaberaktie)mehr Analysen

Eintrag hinzufügen

SMI mit neuem Hoch – UBS mit neuem Chef | BX Swiss TV

Finanzen.net News

pagehit
;